This section features information on all TRANSCAN funded projects by country and funding organization. Click on a country/funding organization to find out what projects have been financed by a specific country/funding organization.
Airborne biomarkers for colorectal cancers
The ANswer within the microEnvironment: Malignant pleural mesothelioma resistance to Old and NEw drugs
Approaching recurrence and resistance mechanisms in esophagogastric adenocarcinomas from the prospective MEMORI trial
A randomized, 2x2 biomarker prevention trial of low-dose aspirin and metformin in colon cancer patients
Exploiting the peptidome of atypical teratoid/rhabdoid tumors - characterization of novel tumor-associated antigens for immunotherapy in order to maintain long-term remissions
Patient-derived models for intratumor functional heterogeneity and its implications for personalized medicine
Bispecific antibodies in Lymphoma: Microenvironmental profiling to predict treatment response and uncover immunogenic resistance mechanisms
Biomarkers for diagnosis and prognosis of endometrial carcinoma
Biomarkers of tumor recurrence in pancreatic cancer
K-RAS mutations and DNA repair function in NSCLC
Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors
MicroRNAs methylation and expression profiling for identification of breast cancer patients at high risk to develop distant metastases
Breast Clinical impact of intratumor heterogeneity in metastatic breast cancer
Cancer evolution and identification of relapse-initiating cells
Characterization of stromal and innate lymphoid cell populations involved in immunotherapy resistance in High-Grade Serous Ovarian
Validation of multiparametric models and Circulating and imaging biomarkers to improve Lung cancer EARLY detection
Circulating Tumor Cells as Biomarker for Minimal Residual Disease in Prostate Cancer
A randomized phase II study for tertiary prevention of squamocellular cancer of head and neck (SCCHN) with a dietary intervention
Impact of dietary intervention on tumor immunity
Defeating Recurrence and resistance in AML:Multigenomic Approaches to analyse heterogeneity
Dual epigenetic targeting and immunotherapy to fight against cancer
An integrated approach for epigenetic risk assessment and biomarker development for breast cancer in prospective cohorts / Identifying early epigenetic predictors of breast cancer risk and their etiology determinants
Implementation of (epi)genetic and metabolic networks in the targeting of T-cell prolymphocytic leukemia
Detection of early esophageal cancer by near-infrared fluorescence molecular endoscopy
Early prediction of efficacy of endocrine therapy in breast cancer: pilot study and validation with 18F Fluoroestradiol (FES) PET/CT
An integrated European platform to conduct translational studies in myelodysplastic syndromes based on the EuroBloodNet infrastructure
Translational Research in Peripheral T-Cell Lymphomas: from characterization to novel targets
Cancer prevention through improved familial risk assessment and gene discovery
Fighting Resistance in CLL
Biomarkers related to folate-dependent one-carbon metabolism in CRC recurrence and survival
Genetic and cellular intratumor heterogeneity as predictor of chronic lymphocytic leukemia outcome and treatment resistance
Identification of genetic markers involved in development of metastases and second cancers in melanoma
Subscribe to our Newsletter You can unsubscribe at any moment by clicking on the subscription preferences link at the bottom of a received newsletter.
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No. 964264.
Legal Notice | Privacy Policy